NL8002094A - Diagnostische methode. - Google Patents
Diagnostische methode. Download PDFInfo
- Publication number
- NL8002094A NL8002094A NL8002094A NL8002094A NL8002094A NL 8002094 A NL8002094 A NL 8002094A NL 8002094 A NL8002094 A NL 8002094A NL 8002094 A NL8002094 A NL 8002094A NL 8002094 A NL8002094 A NL 8002094A
- Authority
- NL
- Netherlands
- Prior art keywords
- cancer
- concentration
- protein
- value
- serum
- Prior art date
Links
Classifications
-
- G01N33/5755—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G01N33/57585—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G01N2333/4704—Inhibitors; Supressors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/50—Fibroblast growth factors [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Sink And Installation For Waste Water (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2873279A | 1979-04-10 | 1979-04-10 | |
| US2873279 | 1979-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8002094A true NL8002094A (nl) | 1980-10-14 |
Family
ID=21845111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8002094A NL8002094A (nl) | 1979-04-10 | 1980-04-09 | Diagnostische methode. |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS55143441A (OSRAM) |
| KR (1) | KR830002502A (OSRAM) |
| AR (1) | AR222700A1 (OSRAM) |
| AT (1) | AT365343B (OSRAM) |
| AU (1) | AU536522B2 (OSRAM) |
| BE (1) | BE882669A (OSRAM) |
| CH (1) | CH644453A5 (OSRAM) |
| DE (1) | DE3013837A1 (OSRAM) |
| DK (1) | DK149980A (OSRAM) |
| ES (1) | ES8103380A1 (OSRAM) |
| FI (1) | FI801078A7 (OSRAM) |
| FR (1) | FR2454099A1 (OSRAM) |
| GB (1) | GB2047712B (OSRAM) |
| GR (1) | GR67692B (OSRAM) |
| HU (1) | HU183122B (OSRAM) |
| IE (1) | IE49981B1 (OSRAM) |
| IL (1) | IL59772A (OSRAM) |
| IT (1) | IT1143135B (OSRAM) |
| LU (1) | LU82345A1 (OSRAM) |
| NL (1) | NL8002094A (OSRAM) |
| NO (1) | NO801018L (OSRAM) |
| PH (1) | PH15637A (OSRAM) |
| SE (1) | SE8002602L (OSRAM) |
| ZA (1) | ZA802141B (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3524644A1 (de) * | 1985-07-10 | 1987-01-15 | Heyl Chem Pharm | Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung |
-
1980
- 1980-03-28 PH PH23825A patent/PH15637A/en unknown
- 1980-04-03 IE IE693/80A patent/IE49981B1/en unknown
- 1980-04-03 AU AU57193/80A patent/AU536522B2/en not_active Ceased
- 1980-04-03 SE SE8002602A patent/SE8002602L/ not_active Application Discontinuation
- 1980-04-03 FI FI801078A patent/FI801078A7/fi not_active Application Discontinuation
- 1980-04-04 FR FR8007691A patent/FR2454099A1/fr active Granted
- 1980-04-04 IL IL59772A patent/IL59772A/xx unknown
- 1980-04-04 BE BE0/200139A patent/BE882669A/fr not_active IP Right Cessation
- 1980-04-07 JP JP4475080A patent/JPS55143441A/ja active Pending
- 1980-04-08 DK DK149980A patent/DK149980A/da not_active IP Right Cessation
- 1980-04-08 LU LU82345A patent/LU82345A1/fr unknown
- 1980-04-09 NO NO801018A patent/NO801018L/no unknown
- 1980-04-09 ES ES490396A patent/ES8103380A1/es not_active Expired
- 1980-04-09 IT IT48370/80A patent/IT1143135B/it active
- 1980-04-09 NL NL8002094A patent/NL8002094A/nl not_active Application Discontinuation
- 1980-04-10 ZA ZA00802141A patent/ZA802141B/xx unknown
- 1980-04-10 HU HU80871A patent/HU183122B/hu unknown
- 1980-04-10 GB GB8011902A patent/GB2047712B/en not_active Expired
- 1980-04-10 KR KR1019800001518A patent/KR830002502A/ko not_active Ceased
- 1980-04-10 DE DE19803013837 patent/DE3013837A1/de not_active Withdrawn
- 1980-04-10 AT AT0195780A patent/AT365343B/de not_active IP Right Cessation
- 1980-04-10 GR GR61652A patent/GR67692B/el unknown
- 1980-04-10 AR AR280624A patent/AR222700A1/es active
- 1980-04-10 CH CH277880A patent/CH644453A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR830002502A (ko) | 1983-05-30 |
| FR2454099B1 (OSRAM) | 1984-01-27 |
| NO801018L (no) | 1980-10-13 |
| IE800693L (en) | 1980-10-10 |
| LU82345A1 (fr) | 1980-12-16 |
| IE49981B1 (en) | 1986-01-22 |
| DK149980A (da) | 1980-10-11 |
| JPS55143441A (en) | 1980-11-08 |
| IT8048370A0 (it) | 1980-04-09 |
| ES490396A0 (es) | 1981-02-16 |
| GB2047712B (en) | 1983-02-23 |
| GR67692B (OSRAM) | 1981-09-07 |
| GB2047712A (en) | 1980-12-03 |
| AR222700A1 (es) | 1981-06-15 |
| AU5719380A (en) | 1980-10-16 |
| DE3013837A1 (de) | 1980-10-30 |
| ZA802141B (en) | 1981-04-29 |
| IT1143135B (it) | 1986-10-22 |
| FR2454099A1 (fr) | 1980-11-07 |
| AT365343B (de) | 1982-01-11 |
| IL59772A (en) | 1983-05-15 |
| ES8103380A1 (es) | 1981-02-16 |
| IL59772A0 (en) | 1980-06-30 |
| AU536522B2 (en) | 1984-05-10 |
| HU183122B (en) | 1984-04-28 |
| SE8002602L (sv) | 1980-12-09 |
| CH644453A5 (fr) | 1984-07-31 |
| PH15637A (en) | 1983-03-11 |
| ATA195780A (de) | 1981-05-15 |
| FI801078A7 (fi) | 1981-01-01 |
| BE882669A (fr) | 1980-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hastka et al. | Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry | |
| Buzanovskii | Determination of proteins in blood. Part 1: Determination of total protein and albumin | |
| Gordon et al. | Analysis of serum cancer procoagulant activity and its possible use as a tumor marker | |
| Sonnenblick et al. | Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma. | |
| HU188057B (en) | Analytical process based on reaction of antigene-antibody and reagent for the process | |
| US4270924A (en) | Diagnostic method for detecting cancer | |
| Schwartz et al. | Quantitative assay of erythrocyte “free” and zinc-protoporphyrin: Clinical and genetic studies | |
| WO2021045180A1 (ja) | 胃がんマーカー、及びこれを用いた検査方法 | |
| NL8002094A (nl) | Diagnostische methode. | |
| US5260186A (en) | Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (SCM) test | |
| KR102713301B1 (ko) | 췌장암 및 췌장관 내 유두상 점액성 종양의 마커 | |
| CN101305100A (zh) | 液相半乳糖氧化酶希夫测定法 | |
| Glen | Measurement of DNA and RNA in human peripheral blood lymphocytes | |
| Buffone et al. | Characterization and evaluation of immunochemical methods for the measurement of fecal α 1-antitrypsin | |
| Fernandez et al. | A preliminary study of urinary transferrin as a marker for prostatic cancer | |
| US4424278A (en) | Cancer detection procedure using an acyl carrier protein | |
| RU2137420C1 (ru) | Способ выявления "группы опухолевого риска" и скрининга ранних стадий опухолевых заболеваний | |
| Colleen et al. | Carcinoembryonic Antigen in Urine in Patients with Urothelial Carcinoma: An Expression for the Extent of Inflammatory Reaction of the Urinary Tract | |
| US20240302374A1 (en) | Spectrographic detection of acute leukemia | |
| Hamre et al. | Hematologic values for normal healthy men 16 to 25 years of age | |
| RU2085945C1 (ru) | Способ диагностики онкологического заболевания | |
| RU2039985C1 (ru) | Способ диагностики злокачественного заболевания и его рецидива | |
| CN106187853B (zh) | 一种化合物及其制备方法和应用 | |
| Anh-Tuan et al. | Detection and quantitation of hepatitis B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. II. Circulating immune complexes (CICs) in patients with hepatitis B and asymptomatic HBsAg carriers | |
| EP0862739B1 (en) | Method for screening for prostate cancer by measuring apolipoprotein d levels in body fluid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CNR | Transfer of rights (patent application after its laying open for public inspection) |
Free format text: BAYLOR COLLEGE OF MEDICINE |
|
| A85 | Still pending on 85-01-01 | ||
| BV | The patent application has lapsed |